244 related articles for article (PubMed ID: 17051636)
1. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
Cui JF; Liu YK; Zhang LJ; Shen HL; Song HY; Dai Z; Yu YL; Zhang Y; Sun RX; Chen J; Tang ZY; Yang PY
Proteomics; 2006 Nov; 6(22):5953-61. PubMed ID: 17051636
[TBL] [Abstract][Full Text] [Related]
2. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
[TBL] [Abstract][Full Text] [Related]
4. Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins.
Cui JF; Liu YK; Pan BS; Song HY; Zhang Y; Sun RX; Chen J; Feng JT; Tang ZY; Yu YL; Shen HL; Yang PY
J Cancer Res Clin Oncol; 2004 Oct; 130(10):615-22. PubMed ID: 15243804
[TBL] [Abstract][Full Text] [Related]
5. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
6. Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinoma.
Chen RX; Song HY; Dong YY; Hu C; Zheng QD; Xue TC; Liu XH; Zhang Y; Chen J; Ren ZG; Liu YK; Cui JF
PLoS One; 2014; 9(3):e88543. PubMed ID: 24614035
[TBL] [Abstract][Full Text] [Related]
7. Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3.
Sun H; Wang C; Hu B; Gao X; Zou T; Luo Q; Chen M; Fu Y; Sheng Y; Zhang K; Zheng Y; Ren X; Yan S; Geng Y; Yang L; Dong Q; Qin L
Signal Transduct Target Ther; 2021 May; 6(1):187. PubMed ID: 34035222
[TBL] [Abstract][Full Text] [Related]
8. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
Bjørnland K; Winberg JO; Odegaard OT; Hovig E; Loennechen T; Aasen AO; Fodstad O; Maelandsmo GM
Cancer Res; 1999 Sep; 59(18):4702-8. PubMed ID: 10493528
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of S100A4 expression in human hepatocellular carcinoma.
Liu Z; Liu H; Pan H; Du Q; Liang J
J Int Med Res; 2013 Apr; 41(2):457-62. PubMed ID: 23781010
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.
Berge G; Pettersen S; Grotterød I; Bettum IJ; Boye K; Mælandsmo GM
Int J Cancer; 2011 Aug; 129(4):780-90. PubMed ID: 20957651
[TBL] [Abstract][Full Text] [Related]
11. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
12. Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells.
Ma X; Yang Y; Wang Y; An G; Lv G
Cancer Lett; 2010 Dec; 299(2):171-81. PubMed ID: 20855150
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-beta-mediated cancer cell invasiveness.
Matsuura I; Lai CY; Chiang KN
Biochem J; 2010 Feb; 426(3):327-35. PubMed ID: 20070253
[TBL] [Abstract][Full Text] [Related]
14. S100A4 promotes squamous cell laryngeal cancer Hep-2 cell invasion via NF-kB/MMP-9 signal.
Zhang W; Liu Y; Wang CW
Eur Rev Med Pharmacol Sci; 2014; 18(9):1361-7. PubMed ID: 24867514
[TBL] [Abstract][Full Text] [Related]
15. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling.
Cao WH; Liu HM; Liu X; Li JG; Liang J; Liu M; Niu ZH
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):609-17. PubMed ID: 23543443
[TBL] [Abstract][Full Text] [Related]
16. Hypomethylation-induced expression of S100A4 increases the invasiveness of laryngeal squamous cell carcinoma.
Liu J; Guo Y; Fu S; Yang M; Sun KL; Fu WN
Oncol Rep; 2010 Apr; 23(4):1101-7. PubMed ID: 20204297
[TBL] [Abstract][Full Text] [Related]
17. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.
Saleem M; Kweon MH; Johnson JJ; Adhami VM; Elcheva I; Khan N; Bin Hafeez B; Bhat KM; Sarfaraz S; Reagan-Shaw S; Spiegelman VS; Setaluri V; Mukhtar H
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14825-30. PubMed ID: 16990429
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteome analysis of HCC cell lines with different metastatic potentials by SILAC.
Chen N; Sun W; Deng X; Hao Y; Chen X; Xing B; Jia W; Ma J; Wei H; Zhu Y; Qian X; Jiang Y; He F
Proteomics; 2008 Dec; 8(23-24):5108-18. PubMed ID: 19016532
[TBL] [Abstract][Full Text] [Related]
19. S100A4 antisense oligodeoxynucleotide suppresses invasive potential of neuroblastoma cells.
Gao XN; Tang SQ; Zhang XF
J Pediatr Surg; 2005 Apr; 40(4):648-52. PubMed ID: 15852272
[TBL] [Abstract][Full Text] [Related]
20. Nano-LC-MS/MS based proteomics of hepatocellular carcinoma cells compared to Chang liver cells and tanshinone IIA induction.
Long X; Zhang J; Zhang Y; Yao J; Cai Z; Yang P
Mol Biosyst; 2011 May; 7(5):1728-41. PubMed ID: 21423987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
